Beta Bionics, Inc.
NASDAQ:BBNXMedical - Equipment & Services
+$0.42 today
- Market cap
- $644.70M
- Beta
- 3.39
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$1.50
Volume 1.38M
Average 0.99M
BBNX Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
Beta Bionics, Inc.NASDAQ: BBNX
Property, Plant & Equipment (Net) · Q1 FY2026 · quarter ended Mar 2026
Property, plant & equipment (net) rises 38.2% from a year ago
Property, plant & equipment (net) stood at $16.39M at the end of Q1 FY2026, up 38.2% from a year earlier and up 7.6% from the prior quarter. Over 3 fiscal years it compounded at +30.4% a year.
Context
- Property, plant & equipment (net) amounted to 5.4% of total assets at the end of Q1 FY2026, up 1.9 pp from a year earlier.
- Property, plant & equipment (net) increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether property, plant & equipment (net) keeps rising in the next quarterly balance sheet after a +38.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Property, Plant & Equipment (Net) history
USD · from the balance sheet
- Latest · FY2025
- 15.23M USD
- Year-over-year change
- +33.3%
- 3-year CAGR
- +30.4%
| Period | Period end | Property, Plant & Equipment (Net) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 15.23M | +33.3% |
| FY2024 | 2024-12-31 | 11.42M | +84.3% |
| FY2023 | 2023-12-31 | 6.2M | -9.7% |
| FY2022 | 2022-12-31 | 6.87M | — |
Property, Plant & Equipment (Net) vs competitors
How BBNX compares with its peers on the latest reported figures
- Peers report in different currencies, so property, plant & equipment (net) is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +38.2% is the highest of 7, against a peer median of +11.0%.
- Property, plant & equipment (net) amounts to 5.4% of total assets for BBNX, versus a peer median of 15.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | DKK 231.76B DKK | +28.2% | +46.2% | 39.0% | |
| Jun 2026 | $1.67B USD | +10.0% | +13.0% | 25.8% | |
| Jun 2026 | $858.6M USD | +19.2% | +11.3% | 27.1% | |
MMEDMiniMed Group, Inc. Common Stock | Jul 2026 | $736M USD | — | — | 15.6% |
| Mar 2026 | $178.99M USD | -0.7% | +0.1% | 15.5% | |
| Mar 2026 | $93.85M USD | +12.0% | +22.2% | 12.6% | |
| Mar 2026 | $16.39M USD | +38.2% | +30.4% | 5.4% | |
| Mar 2026 | $1.25M USD | -44.3% | -9.6% | 0.5% | |
| Peer median (excluding BBNX) | — | +11.0% | +12.1% | 15.6% | |
Competitors are the stored peer set for BBNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Beta Bionics, Inc.
NASDAQ:BBNX
Intrinsic Alpha fair value
Locked
Current Price
$14.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.